Tirzepatide, semaglutide, and liraglutide vs DPP4i were associated with lower risk of alcohol use disorder, especially among men and younger patients.

The medications seem to dampen the effects of drugs ranging from nicotine to alcohol—but scientists haven’t been able to ...

This article was reviewed by Darragh O’Carroll, MD. Oral vs. Injectable Semaglutide: Effectiveness & Side Effects Key ...

A small study helps explain why some people taking Wegovy and similar weight-loss drugs cut back on alcohol, offering insight ...

A new deal with major drugmakers, unveiled by U.S. President Donald Trump on Thursday, aims to expand coverage and cut prices ...

GLP-1 medications such as Ozempic and Wegovy appear to make people feel less drunk and reduce alcohol cravings by delaying ...

A 67-year-old man presented with multiorgan failure, hypoglycaemia, cholestatic liver dysfunction, and two duodenal ulcers ...

Research has suggested the potential of GLP-1 medications for treating substance use disorders, including alcohol, opioids, ...

Popular drugs for diabetes management and weight loss, such as Ozempic and Wegovy, could also be effective in reducing ...

GLP-1s hold promise as a potential treatment for alcohol and substance use disorders, according to an expert endocrine ...

Approximately 178,000 people die from excessive drinking each year. But researchers say popular weight loss drugs could help ...

The FDA has approved Rybelsus, the first oral GLP-1 receptor agonist, for managing cardiovascular risks in adults. This ...